CompassNow live for financial advisors
Latigo Bio stock

Latigo Bio Stock

HealthTech

Looking to sell Latigo Bio stock or options?

Founded: 2018Funding to Date: $287.9Mhttps://www.latigobio.com

Latigo Bio is a biotechnology company focused on creating new, non-opioid treatments for chronic pain. Their platform uses translated insights to offer a unique method for developing therapeutics that can cross the blood-nerve barrier. This approach aims to provide patients with pain management options that do not lead to addiction, dependence, or tolerability issues.

Own Latigo Bio stock or options?

Get an instant valuation

  • Completely free
  • 100% confidential & secure
  • Takes less than a minute
100% private & secure